Peter Armstrong Thompson
10Patents
4h-index
20Co-inventors
56Inventor score
Filing activity: Jul 25, 2006 → Jul 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8409577B2 | Single chain multivalent binding proteins with effector function | Chemistry; Metallurgy | 111 | Active |
| US8632774B2 | Antagonists of IL-6 | Chemistry; Metallurgy | 16 | Active |
| US9101609B2 | CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof | Chemistry; Metallurgy | 12 | Active |
| US9493564B2 | CD86 antagonist multi-target binding proteins | Chemistry; Metallurgy | 9 | Active |
| US10988543B2 | Humanized anti-tumor necrosis factor alpha receptor 2 (anti-TNFR2) antibodies and methods of use thereof to elicit an immune response against a tumor | Chemistry; Metallurgy | 4 | Active |
| US7846434B2 | Materials and methods for improved immunoglycoproteins | Chemistry; Metallurgy | 2 | Active |
| US10307481B2 | CD37 immunotherapeutics and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11541126B1 | Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8383106B2 | Materials and methods for improved immunoglycoproteins | Chemistry; Metallurgy | 0 | Active |
| US10143748B2 | B-cell reduction using CD37-specific and CD20-specific binding molecules | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.